Home/Synlab/Mathieu Floreani
MF

Mathieu Floreani

CEO of SYNLAB Group

Synlab

Synlab Pipeline

DrugIndicationPhase
Routine Laboratory TestingGeneral health screening and disease monitoringCommercial
Chronic Kidney Disease DiagnosticsEarly detection and monitoring of CKDCommercial
Rare Disease DiagnosticsGenetic and molecular diagnosis of rare conditionsCommercial
Pre-Implantation Genetic TestingGenetic screening of embryos before IVFCommercial
Personalized DiagnosticsTailored testing based on individual patient profilesCommercial